Raise closed, search for fresh raises on Seedstage

Safety Harbor, FL

Advancing implantable cardiac monitoring to improve patient outcomes and reduce healthcare costs.

• Innovative device: Provides continuous, real-time cardiac monitoring for proactive heart health management.
• Clinical traction: Successfully implanted in 39 patients with over 60,000 hours of data collected.
• Expert team: Leadership includes veterans from Medtronic, Stanford, and Boston Scientific.
• Strong backing: Supported by Stanford StartX, Johnson & Johnson’s JLABS, and $14 million raised.
• Market potential: Positioned in a growing $65 billion cardiac monitoring market.

Future Cardia is a pioneering med-tech company developing deeply analytical implantable cardiac monitors to transform heart failure management. With a minimally invasive, under-the-skin device, Future Cardia provides continuous real-time data on cardiac health, enabling early detection and proactive intervention. This innovative system monitors electrical activity, heart and lung sounds, and patient movement, securely transmitting data to clinicians for comprehensive, remote care. By bridging the gap in proactive cardiac monitoring, the company aims to reduce hospitalizations, lower healthcare costs, and enhance patient outcomes. Backed by 60,000 hours of clinical data from 39 patients and expertise from industry leaders at Medtronic, Stanford, and Boston Scientific, Future Cardia is at the forefront of personalized heart health solutions.

The funds raised will support Future Cardia’s progress toward commercialization, including FDA 510(k) submission and expanded clinical trials. With a total addressable market projected to exceed $117 billion by 2032, the company is positioned to capture significant opportunities in the growing cardiac monitoring market. As a member of Stanford StartX and Johnson & Johnson’s JLABS, and with $14 million already raised from over 10,000 investors, Future Cardia combines innovative technology, a strong leadership team, and proven market traction to redefine cardiac care for millions globally.

Company Info

Future Cardia develops implantable cardiac monitors providing real-time data to improve outcomes for chronic heart conditions.

Future Cardia is a med-tech company specializing in innovative implantable cardiac monitors designed to provide continuous, real-time monitoring for patients with chronic heart conditions such as heart failure. The minimally invasive device collects critical data, including ECG readings, heart and lung sounds, and patient movement, which is transmitted securely to a cloud-based platform. Clinicians can access this data through a secure web portal, enabling proactive interventions and personalized care. Future Cardia’s technology aims to reduce hospitalizations, lower healthcare costs, and improve patient outcomes by setting a new standard for remote cardiac monitoring.

Backed by Stanford StartX and Johnson & Johnson’s JLABS, Future Cardia has achieved significant milestones, including implanting devices in 39 patients and collecting over 60,000 hours of cardiac data. With a strong team of experts from leading institutions like Medtronic, Boston Scientific, and Stanford, the company is advancing toward FDA 510(k) submission and commercialization. Positioned in the $117 billion cardiac monitoring market, Future Cardia is at the forefront of transforming heart health management through its analytical and minimally invasive solutions.